Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7440053 | 0.91 | AGTR1 (0.39) | AGTR1 | |
| SCHEMBL7443544 | 0.87 | AGTR1 (0.41) | AGTR1 | |
| SCHEMBL7439089 | 0.83 | AGTR1 (0.40) | AGTR1SMN1; SMN2 | |
| SCHEMBL7440007 | 0.83 | AGTR1 (0.40) | AGTR1 | |
| SCHEMBL7434200 | 0.82 | KMT2A (0.40) | AGTR1 | |
| SCHEMBL7432707 | 0.82 | AGTR1 (0.40) | AGTR1SMN1; SMN2 | |
| SCHEMBL7426708 | 0.81 | AGTR1 (0.40) | AGTR1 | |
| SCHEMBL7442152 | 0.81 | AGTR1 (0.37) | AGTR1 | |
| SCHEMBL7438669 | 0.80 | — | — | |
| SCHEMBL7446552 | 0.79 | KMT2A (0.38) | AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0628559-B1 | Pyrimidine compounds and their use as pharmaceuticals | BEIERSDORF LILLY GMBH (DE) | 2002-04-03 | — | — | EP | disclosed |
| US-5602137-A | Pyrimidine compounds and their use as pharmaceuticals | BEIERSDORF-LILLY GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5602136-A | Pyrimidine compounds and their use as pharmaceuticals | BEIERSDORF-LILLY GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5571813-A | Fused pyrimidine compounds and their use as pharmaceuticals | BEIERSDORF-LILLY GMBH (DE) | 1996-11-05 | — | — | US | disclosed |
| EP-0628559-A1 | Pyrimidine compounds and their use as pharmaceuticals | Beiersdorf-Lilly GmbH (DE) | 1994-12-14 | — | — | EP | disclosed |